Unit2Sucks said:
oski003 said:
Unit2Sucks said:
oski003 said:
Unit2Sucks said:
Shocked, just shocked.
Quote:
Reuters: Demand for the COVID-19 vaccine produced by U.S. biotech firm Novavax has been underwhelming in the European Union's main countries in the early rollout, so far undermining hopes that it could convince vaccine sceptics to get a shot.
It only became available in some parts of Germany on March 4 and is only available for primary and secondary (not boost) vaccination for 18+. Give it a little time. Reuters and Politico are the mouthpieces for Pfizer and BioNTech. Their writing is slanted.
https://www.uniklinik-freiburg.de/impfstuetzpunkt-freiburg.html
Oh right, you have a conspiracy theory for everything. Fire Fauci!
You call biased journalism a conspiracy? It is the truth. Pfizer's board has the ex Reuters CEO on Chairman of the Reuters Foundation. The article is misleading, and I have you facts demonstrating such.
Your claim that it is biased is literally a conspiracy theory. You believe the ex Reuters CEO is exercising editorial discretion and/or modifying content. That's lunacy and completely baseless.
I'm not sure why you brought up Politico other than to burnish your conspiracy theorist credentials - I certainly made no reference to them.
If people were so eager for this traditional vaccine tech, like you claim, then they would be clamoring for it now. And it's not just Germany. Please work on your next conspiracy theory.
Quote:
But initial data on Nuvaxovid's rollout show that it has had a small impact on vaccination campaigns.
In Germany, the EU's most populous country and home to more than 10 million unvaccinated adults, only about 38,000 Novavax doses have been administered since the start of the rollout on Feb. 24, according to data from the Robert Koch Institute.
In March so far on average nearly 90,000 COVID-19 vaccines have been administered daily in Germany, mostly boosters. Only three per cent of them were Novavax's, despite over two million doses distributed to the country.
A similar situation is emerging in Italy, where less than 16,000 Nuvaxovid doses have been administered since Feb 28, when the rollout started after the delivery of one million shots to vaccination centres. In the same period, the country injected over 70,000 COVID-19 vaccines a day, largely boosters, data from the government show.
Novavax said its protein-based shot will play a role in driving vaccination among those who have been hesitant to get immunized and it has started an educational effort on vaccine choices.
The arrival of the vaccine so far into the region's campaign which started in late 2020 and amid the easing of restrictive measures were among the reasons for the "disappointing performance," former head of the EU's drugs agency, Guido Rasi, said.
Since you won't address anything I said, I will repeat myself.
It only became available in some parts of Germany on March 4 and is only available for primary and secondary (not boost) vaccination for 18+. Give it a little time. Reuters and Politico are the mouthpieces for Pfizer and BioNTech. Their writing is slanted.
https://www.uniklinik-freiburg.de/impfstuetzpunkt-freiburg.htmlSecondly, the ex CEO of Reuters and Chairman of Reuters Foundation profits from Pfizer's stock price. you are apparently too naive to see the connection between Pfizer adding people like ex FDA head Scott Gottlieb (who is a talking head on the news) and the Reuters ex CEO /Chair and their news coverage. It is very savvy of them.